NCT02242903View on ClinicalTrials.gov

A Study of LY3079514 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

LY3079514

Administered SC

DRUG

LY3079514

Administered IV

DRUG

Placebo

Administered SC

DRUG

Placebo

Administered IV

Trial Locations (1)

91206

California Clinical Trials Medical Group, Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02242903 - A Study of LY3079514 in Healthy Participants | Biotech Hunter | Biotech Hunter